Report: Most federally funded clinical trials for dementia have racially excluding criteria
By
Kristen Fischer
Jul 08, 2024
A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that weren’t...
Older adults in cancer clinical trials don’t have more ER, observational visits, data shows
By
Kristen Fischer
Jun 05, 2024
Older people in clinical trials for cancer didn’t have significantly more emergency room or observational visits compared to those not in trials, but they underwent more hospitalizations, according to...
Behind the push to include more nursing home residents in clinical trials
By
Josh Henreckson
Apr 30, 2024
Nursing home residents — who often deal with complex and overlapping medical conditions — should be included in more clinical trials for therapies and medications, a group of researchers is emphasizing...
Opinion: Even with new law, clinical trials lack data on older adults
By
Kristen Fischer
Apr 17, 2024
Older adults are not represented adequately in clinical trials of medications for disorders that are common in the population. The legal framework to better represent them is in place, but not enough is...
Report endorses adding more nursing home residents in clinical trials, shares framework to do so
By
Kristen Fischer
Mar 18, 2024
A commentary published in the Journal of the American Geriatrics Society on March 14 talks about the need for clinical trials among people living in nursing homes.
Report: Caregivers are left out of Alzheimer’s, dementia clinical trials
By
Kristen Fischer
Aug 22, 2023
A new study explores the lack of integration of family caregivers to support their loved ones with Alzheimer’s disease and related dementias (ADRD) who are part of clinical trials.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Lack of clinical use prompts Biogen to halt real-world Aduhelm drug trial
By
Alicia Lasek (f3)
Jun 28, 2022
The pharmaceutical firm Biogen has stopped a real-world clinical trial for its federally approved Alzheimer’s disease drug aducanumab (Aduhelm).
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
After leading in COVID-19 drug trials, a nursing home chain now partners on dementia drug
By
Kimberly Marselas
May 31, 2022
Principle LTC, operator of 45 nursing homes in the Southeast, is building on its successful role in testing a key drug for COVID-19 prevention and treatment to launch trials of a new Alzheimer drug.